SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome

References

• Muchardt C, Yaniv M. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol. 1999;293:187–198.
   PubMed Web of Science ®Google Scholar
• Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene. 2009;28:1653–1668.
   PubMed Web of Science ®Google Scholar
• Wilson BG, Wang X, Shen X, et al. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell. 2010;18:316–328.
   PubMed Web of Science ®Google Scholar
• Neely KE, Hassan AH, Brown CE, et al. Transcription activator interactions with multiple SWI/SNF subunits. Mol Cell Biol. 2002;22:1615–1625.
   PubMed Web of Science ®Google Scholar
• Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74–79.
   PubMed Web of Science ®Google Scholar
• Biegel JA, Tan L, Zhang F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002;8:3461–3467.
   PubMed Web of Science ®Google Scholar
• Roberts CW, Leroux MM, Fleming MD, et al. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer. 2004;4:133–142.
   PubMed Web of Science ®Google Scholar
• Medina PP, Romero OA, Kohno T, et al. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat. 2008;29:617–622.
   PubMed Web of Science ®Google Scholar
• Roberts CW, Leroux MM, Fleming MD, et al. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell. 2002;2:415–425.
   PubMed Web of Science ®Google Scholar
• Alvarez JD, Yasui DH, Niida H, et al. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev. 2000;14:521–535.
   PubMed Web of Science ®Google Scholar
• Notani D, Gottimukkala KP, Jayani RS, et al. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010;8:e1000296.
   PubMed Web of Science ®Google Scholar
• Pavan Kumar P, Purbey PK, Sinha CK, et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell. 2006;22:231–243.
   PubMed Web of Science ®Google Scholar
• Dickinson LA, Joh T, Kohwi Y, et al. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell. 1992;70:631–645.
   PubMed Web of Science ®Google Scholar
• Yasui D, Miyano M, Cai S, et al. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature. 2002;419:641–645.
   PubMed Web of Science ®Google Scholar
• Wen J, Huang S, Rogers H, et al. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood. 2005;105:3330–3339.
   PubMed Web of Science ®Google Scholar
• Mir R, Pradhan SJ, Patil P, et al. Wnt/beta-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene. 2016;35:1679–1691.
   PubMed Web of Science ®Google Scholar
• Wang Q, Qian J, Wang F, et al. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis. Oncol Rep. 2012;28:2029–2034.
   PubMed Web of Science ®Google Scholar
• Gong J, Tu W, Han J, et al. Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx. Sci Rep. 2016;6:37717.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu X, Zhang G, et al. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21. Blood. 2014;123:3452–3461.
   PubMed Web of Science ®Google Scholar
• Isakoff MS, Sansam CG, Tamayo P, et al. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci USA. 2005;102:17745–17750.
   PubMed Web of Science ®Google Scholar
• Wang X, Werneck MB, Wilson BG, et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest. 2011;121:3834–3845.
   PubMed Web of Science ®Google Scholar
• Diboun I, Wernisch L, Orengo CA, et al. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006;7:252.
   PubMed Web of Science ®Google Scholar
• Feng J, Liu T, Qin B, et al. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7:1728–1740.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, He QY. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382–2383.
   PubMed Web of Science ®Google Scholar
• McKenna ES, Sansam CG, Cho YJ, et al. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol. 2008;28:6223–6233.
   PubMed Web of Science ®Google Scholar
• Wang Y, Su M, Zhou LL, et al. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription. Blood. 2011;117:3826–3835.
   PubMed Web of Science ®Google Scholar
• Knutson SK, Warholic NM, Wigle TJ, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci USA. 2013;110:7922–7927.
   PubMed Web of Science ®Google Scholar
• Han HJ, Russo J, Kohwi Y, et al. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature. 2008;452:187–193.
   PubMed Web of Science ®Google Scholar
• Li QQ, Chen ZQ, Xu JD, et al. Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci. 2010;101:80–86.
   PubMed Web of Science ®Google Scholar
• Li QQ, Chen ZQ, Cao XX, et al. Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ. 2011;18:16–25.
   PubMed Web of Science ®Google Scholar
• Meng WJ, Yan H, Zhou B, et al. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis. 2012;27:143–150.
   PubMed Web of Science ®Google Scholar
• Tu W, Luo M, Wang Z, et al. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int. 2012;32:1064–1078.
   PubMed Web of Science ®Google Scholar
• Chen H, Takahara M, Oba J, et al. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci. 2011;64:39–44.
   PubMed Web of Science ®Google Scholar
• Lu X, Cheng C, Zhu S, et al. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep. 2010;24:981–987.
   PubMed Web of Science ®Google Scholar
• Gutierrez J, Paredes R, Cruzat F, et al. Chromatin remodeling by SWI/SNF results in nucleosome mobilization to preferential positions in the rat osteocalcin gene promoter. J Biol Chem. 2007;282:9445–9457.
   PubMed Web of Science ®Google Scholar
• Medina PP, Sanchez-Cespedes M. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer. Epigenetics. 2008;3:64–68.
   PubMed Web of Science ®Google Scholar
• Masliah-Planchon J, Bieche I, Guinebretiere JM, et al. SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol Mech Dis. 2015;10:145–171.
   PubMed Web of Science ®Google Scholar